Specialists for Amyotrophic lateral sclerosis

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Andrew Geronimo, PhD
Rare Disease Specialist
Milton S. Hershey Medical Center
Hershey, Pennsylvania
QC-verified PI×2
Timothy M Miller, MD, PhD
Rare Disease / Clinical Research
Washington University School of Medicine
QC-verified PI×2
Junwei Hao, MD; PhD
Rare Disease Specialist
Xuanwu Hospital ,Capital Medical University
Beijing, Beijing Municipality
QC-verified
Eugenio Mercuri, MD
Rare Disease Specialist
Istituto Gaslini
Genova
PI×3
Alberto Benussi, MD
Rare Disease Specialist
Università degli Studi di Brescia
Trieste, Trieste
PI×5
Urielle Desalbres
Rare Disease / Clinical Research
AP-HM
PI×24 1
Daniel Fowler, M.D.
Rare Disease Specialist
Rapa Therapeutics LLC
Boston, Massachusetts
PI×3
Central Contact
Rare Disease / Clinical Research
Astellas Pharma Global Development
PI×26
Barbara Borroni, MD
Rare Disease / Clinical Research
Azienda Ospedaliera Spedali Civili, Brescia
PI×7
Giancarlo Comi, MD
Rare Disease / Clinical Research
San Raffaele Hospital
PI×3 1
Jeremy Shefner, MD, PhD, M.D
Rare Disease / Clinical Research
State University of New York - Upstate Medical University
PHOENIX, AZ
PI×6
Rebecca Gibson
Rare Disease / Clinical Research
Stryker Trauma & Extremities
PI×6 13
Kenneth H Fischbeck, M.D., M.D
Rare Disease / Clinical Research
National Institute of Neurological Disorders and Stroke (NINDS)
BETHESDA, MD
PI×6
Thomas Meyer, Prof. Dr.
Rare Disease Specialist
Ambulanzpartner Soziotechnologie APST GmbH
Berlin
PI×2
Jakub M Antczak, MD
Rare Disease Specialist
Jagiellonian University Medical College, Department of Neurology
Krakow, Lesser Poland Voivodeship
PI×6
Harrison Jones, PhD
Rare Disease / Clinical Research
Duke University
PI×5
Petra Kaufmann, MD, M.D
Rare Disease / Clinical Research
Columbia University
NEW YORK, NY
PI×2
General Manager
Rare Disease / Clinical Research
Tanabe Pharma Corporation
PI×17 6
Shan Ye
Peking University Third Hospital
PI×2
Todd D Levine, MD
Rare Disease / Clinical Research
Phoenix Neurological Associates, LTD
PI×4
Yilong Wang, MD,PhD
Rare Disease / Clinical Research
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
PI×3
Maja Kojović, PhD, MD
Rare Disease / Clinical Research
University Medical Centre Ljubljana
PI×2
Jacqueline Montes, Pt, EdD
Rare Disease Specialist
Columbia University
New York, New York
PI×5
Kathryn J Swoboda, MD
Rare Disease / Clinical Research
University of Utah
SACRAMENTO, CA
PI×2
Barbara K Smith, PT, PhD
Rare Disease / Clinical Research
University of Florida
PI×3
Richard Barohn, MD, M.D
Rare Disease / Clinical Research
University of Kansas Medical Center
COLUMBIA, MO
PI×3
Mary Kay Floeter, M.D.
Rare Disease / Clinical Research
National Institute of Neurological Disorders and Stroke (NINDS)
PI×5
Jeffrey Statland, MD, MD
Rare Disease / Clinical Research
University of Kansas Medical Center
KANSAS CITY, KS
PI×7
ALL ALS Patient Navigator
Rare Disease Specialist
University of Alabama Birmingham
Birmingham, Alabama
Isabelle DESGUERRE, MD, PhD
Rare Disease Specialist
Hôpital Necker-Enfants Malades
Paris
PI×2
Najeebah Abdul-Musawir, MD,MBA
Rare Disease / Clinical Research
Supernus Pharmaceuticals, Inc.
PI×2
ILHAN KARACAN, MD
Rare Disease / Clinical Research
Bagcilar Training & Research Hospital
PI×5 1
Richard Finkel, MD
Rare Disease / Clinical Research
Children's Hospital of Philadelphia
PI×3
Karunesh Ganguly, MD, PhD
Rare Disease Specialist
University of California San Francisco
San Francisco, California
Laura Andres-Martin
Rare Disease Specialist
The New York Stem Cell Foundation Research Institute
New York, New York
PI×3 1
Kazunori Saeki
Neuroscience Clinical Development Section. JAC PCU. Eisai Co., Ltd.
QC-verified PI×3
Lucette Lacomblez
Pitié-Salpêtrière Hospital
QC-verified PI×2
Robert Miller
Mayo Clinic
QC-verified PI×2
Ole-Bjørn Tysnes
Haukeland University Hospital
QC-verified PI×3
Tomohiro Kuwayama
Ono Pharmaceutical Co. Ltd
QC-verified PI×2
Pierre Clavelou
University Hospital, Clermont-Ferrand
QC-verified PI×2
Michael D Weiss
University of Washington Medical School
QC-verified PI×3
Edward Kasarskis, MD
University of Kentucky
LEXINGTON, KY
QC-verified PI×2
Shafeeq Ladha, M.D
Barrow Neurological Institute
PHOENIX, AZ
QC-verified PI×2
Michael Silverman
Samus Therapeutics
QC-verified PI×2
Jason Thonhoff, M.D., Ph.D
The Methodist Hospital Research Institute
HOUSTON, TX
QC-verified PI×1
Terry D Heiman-Patterson, MD
Drexel University College of Medicine
PHILADELPHIA, PA
QC-verified PI×2
Kimberly Johnson
Duke University
QC-verified PI×1
Sean Smith
Washington University School of Medicine
QC-verified PI×1
Urvi Desai
Neurologist/ MDA Director
QC-verified PI×1
Hiroshi Mistumoto
Columbia University
QC-verified PI×1
Henrik D Schroeder
Odense University Hospital
QC-verified PI×1
Maoxin Yue, M.D
Wujing People's Hospital
QC-verified PI×1
José Enrique De la Rubia Ortí, Ph
Catholic University of Valencia
QC-verified PI×1
Capucine Pr MORELOT PANZINI
APHP
QC-verified PI×1
Paul H. Gordon
Associate Medical Director, Eleanor and Lou Gehrig MDA/ALS Center, Columbia University Medical Center
QC-verified PI×1
Ming Chan
University of Alberta
QC-verified PI×1
Erik Ensrud, MD
VA Boston Healthcare System
STANFORD, CA
QC-verified PI×1
Chris McDermott
Sheffield Teaching Hospitals NHS FT
QC-verified PI×1
Sanjay Kalra, M.D
FRCPC
ROCHESTER, MN
QC-verified PI×2

More about Amyotrophic lateral sclerosis

Disease overview →
Treatments →
Clinical trials →